BiowaveHOME Neuromodulation Pain Therapy Device— 510(k) K152437

Substantially Equivalent

Biowave Corporation

FDA 510(k) clearance K152437 for BiowaveHOME Neuromodulation Pain Therapy Device, Substantially Equivalent on 2015-09-25. Applicant: Biowave Corporation.

Clearance details

Applicant
Biowave Corporation
Product code
Code GZJ
Advisory panel
Neurology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Norwalk, CT, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.